TRIB
Income statement / Annual
Last year (2023), Trinity Biotech plc's total revenue was $56.83 M,
a decrease of 24.00% from the previous year.
In 2023, Trinity Biotech plc's net income was -$24.02 M.
See Trinity Biotech plc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$56.83 M |
$74.78 M |
$92.97 M |
$101.98 M |
$90.44 M |
$97.04 M |
$99.14 M |
$99.61 M |
$100.20 M |
$104.87 M |
| Cost of Revenue |
$37.38 M
|
$52.73 M
|
$54.89 M
|
$53.40 M
|
$52.32 M
|
$55.59 M
|
$57.25 M
|
$56.52 M
|
$53.95 M
|
$54.52 M
|
| Gross Profit |
$19.45 M
|
$22.05 M
|
$38.08 M
|
$48.58 M
|
$38.12 M
|
$41.45 M
|
$41.89 M
|
$43.09 M
|
$46.25 M
|
$50.35 M
|
| Gross Profit Ratio |
0.34
|
0.29
|
0.41
|
0.48
|
0.42
|
0.43
|
0.42
|
0.43
|
0.46
|
0.48
|
| Research and Development Expenses |
$4.38 M
|
$4.14 M
|
$4.50 M
|
$5.08 M
|
$5.33 M
|
$5.37 M
|
$5.66 M
|
$5.04 M
|
$5.07 M
|
$4.29 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$24.68 M
|
$25.07 M
|
$27.58 M
|
$29.50 M
|
$30.85 M
|
$30.80 M
|
$28.02 M
|
$28.44 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$32.25 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$31.15 M
|
$29.17 M
|
$24.68 M
|
$25.07 M
|
$27.58 M
|
$29.50 M
|
$30.85 M
|
$30.80 M
|
$28.02 M
|
$28.44 M
|
| Other Expenses |
$10.96 M
|
-$343,000.00
|
-$4.67 M
|
-$1.86 M
|
-$91,000.00
|
-$102,000.00
|
-$100,000.00
|
$135,000.00
|
$201,000.00
|
$252,000.00
|
| Operating Expenses |
$46.50 M
|
$32.96 M
|
$24.51 M
|
$28.30 M
|
$32.82 M
|
$34.77 M
|
$36.41 M
|
$35.60 M
|
$32.80 M
|
$32.31 M
|
| Cost And Expenses |
$83.88 M
|
$85.69 M
|
$79.40 M
|
$81.70 M
|
$85.13 M
|
$90.35 M
|
$93.66 M
|
$92.12 M
|
$86.75 M
|
$86.83 M
|
| Interest Income |
$1.17 M
|
$303,000.00
|
$3,000.00
|
$36,000.00
|
$464,000.00
|
$735,000.00
|
$808,000.00
|
$2.43 M
|
$12.91 M
|
$96,000.00
|
| Interest Expense |
$10.15 M
|
$24.75 M
|
$5.46 M
|
$5.54 M
|
$4.95 M
|
$4.39 M
|
$4.68 M
|
$4.73 M
|
$3.48 M
|
$69,000.00
|
| Depreciation & Amortization |
$1.78 M
|
$2.33 M
|
$2.74 M
|
$3.08 M
|
$4.89 M
|
$4.12 M
|
$5.20 M
|
$5.82 M
|
$5.64 M
|
$4.50 M
|
| EBITDA |
-$24.10 M |
-$16.71 M |
$10.59 M |
$21.52 M |
-$19.52 M |
-$13.98 M |
-$29.27 M |
-$30.92 M |
$19.15 M |
$19.93 M |
| EBITDA Ratio |
-0.42
|
-0.11
|
0.17
|
0.22
|
0.06
|
0.08
|
0.06
|
0.1
|
0.26
|
0.17
|
| Operating Income Ratio |
-0.48
|
-0.15
|
0.14
|
0.19
|
0.01
|
0.03
|
0.06
|
0.08
|
0.13
|
0.17
|
| Total Other Income/Expenses Net |
-$9.88 M
|
-$24.43 M
|
-$5.86 M
|
-$6.72 M
|
-$5.89 M
|
-$2.96 M
|
-$2.21 M
|
-$2.26 M
|
$9.49 M
|
-$35,000.00
|
| Income Before Tax |
-$36.93 M
|
-$41.19 M
|
$751,000.00
|
-$6.63 M
|
$821,000.00
|
$3.03 M
|
$1.60 M
|
$5.19 M
|
$22.88 M
|
$18.07 M
|
| Income Before Tax Ratio |
-0.65
|
-0.55
|
0.01
|
-0.07
|
0.01
|
0.03
|
0.02
|
0.05
|
0.23
|
0.17
|
| Income Tax Expense |
-$59,000.00
|
-$192,000.00
|
-$178,000.00
|
-$620,000.00
|
$4.89 M
|
$637,000.00
|
-$697,000.00
|
$41,000.00
|
$1.08 M
|
$853,000.00
|
| Net Income |
-$24.02 M
|
-$41.00 M
|
$875,000.00
|
-$6.01 M
|
-$4.07 M
|
$2.39 M
|
-$40.27 M
|
-$100.63 M
|
$21.80 M
|
$17.21 M
|
| Net Income Ratio |
-0.42
|
-0.55
|
0.01
|
-0.06
|
-0.04
|
0.02
|
-0.41
|
-1.01
|
0.22
|
0.16
|
| EPS |
-0.157 |
-0.304 |
0.01 |
-0.072 |
-0.0485 |
0.0285 |
-0.4655 |
-1.0955 |
0.048 |
0.038 |
| EPS Diluted |
-0.157 |
-0.2635 |
0.01 |
-0.072 |
-0.04 |
0.023 |
-0.3745 |
-0.889 |
0.024 |
0.0365 |
| Weighted Average Shares Out |
$153.10 M
|
$134.94 M
|
$83.61 M
|
$83.61 M
|
$83.61 M
|
$83.61 M
|
$86.49 M
|
$91.86 M
|
$92.65 M
|
$91.00 M
|
| Weighted Average Shares Out Diluted |
$153.10 M
|
$155.50 M
|
$106.52 M
|
$83.61 M
|
$101.87 M
|
$103.51 M
|
$107.51 M
|
$113.20 M
|
$109.63 M
|
$94.87 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
